Statistical Considerations for Clinical Development in China
 View Presentation
*William Wang, Merck Sharp &Dohme Ltd., China Keywords: In recent years, there has been an increasing trend by multinational companies to shift global clinical trials to emerging regions such as China. This presentation will feature the current state of clinical trials in China as well as statistical considerations such as sample size requirements, statistical significance and regional consistency. Data management, reporting practices, and requirements will also be discussed.
|
Key Dates
-
November 1, 2012
Online submission opens for session, short course, roundtable luncheon discussion, and Town Hall proposals -
December 31, 2012
Online submission for a session, short course, and Town Hall proposals closes @ 11:59 pm EDT -
February 12, 2013
Organizing/Planning Meeting, Shady Grove, MD -
March 1, 2013
Roundtable submission closes @ 11:59 pm EDT -
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC
